Nectar Lifesci.
NECLIFE • Pharmaceuticals & Biotechnology
Last Price
₹10.54
Market Cap
₹204.75 Cr
Sector
Pharmaceuticals & Biotechnology
For educational/research use only. Not a recommendation to buy or sell.
At a glance
as of 2026-10-16Sector: Nectar Lifesci. (NECLIFE) is an NSE-listed company in the Pharmaceuticals & Biotechnology sector, within the Pharmaceuticals industry. NSE sector rotation chart
Sharia rating: Nectar Lifesci. is rated Not halal by a specialist third-party provider. Full list of halal NSE stocks
53% below its 52-week high
Price trend
Strongly negative
Over the last 6 months, Nectar Lifesci.'s share price has fallen, doing better than 9% of Pharmaceuticals & Biotechnology stocks.
Institutional activity
Positive
Trading patterns over recent weeks show some signs of institutions buying Nectar Lifesci. (buying score 4/10, selling score 1/10).
Model rank
Strongly positive
Our model's 5-day return score puts Nectar Lifesci. ahead of 99% of NSE stocks. The model is fairly confident in this score (99%).
Ease of trading
Low
Shares change hands easily; there are no signs of trading drying up (risk score 0/10).
Price vs profits
Loss-making
Nectar Lifesci. did not make a profit last year, so there is no profit to compare the price against.
The wider Indian market is in a crisis regime — unusually sharp moves (model 99% sure). This affects every stock's model rank.
Browse ready-made screens →Company Information
About Nectar Lifesci. (NECLIFE)
Nectar Lifesci. is an NSE-listed company operating in the Pharmaceuticals & Biotechnology sector, within the Pharmaceuticals industry (ISIN INE023H01027). This page brings together the quantitative research signals our models compute for NECLIFE: a model-estimated 1-day, 5-day and 21-day return outlook, momentum and trend indicators, institutional-activity context derived from observed trading flows, a snapshot of valuation and quality fundamentals, and the instrument's Sharia-compliance status. All figures are produced by statistical models from historical data and are intended for research and educational purposes.
To read the page, treat the model-estimated return outlook as a relative ranking signal rather than a forecast of price — higher scores reflect stronger model-estimated momentum and trend alignment, not a target or guarantee. The momentum and trend indicators describe how Nectar Lifesci.'s recent price action compares with its own history, while the fundamentals and institutional-activity context add longer-horizon and flow-based perspective. Nothing here is investment advice, a recommendation, or a solicitation to transact; always do your own research and consult a SEBI-registered adviser before making any decision.
The "typical range" we compare a price-to-earnings multiple against is a fixed band for all NSE stocks, not a sector-specific one. Everything on this page describes what our models measured; none of it is a recommendation to do anything.